Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Original Article
M.N. Kosiborod, M.C. Petrie, B.A. Borlaug, J. Butler, M.J. Davies, G.K. Hovingh, D.W. Kitzman, D.V. Møller, M.B. Treppendahl, S. Verma, T.J. Jensen, K. Liisberg, M.L. Lindegaard, W. Abhayaratna, F.Z. Ahmed, T. Ben-Gal, V. Chopra, J.A. Ezekowitz, M. Fu, H. Ito, M. Lelonek, V. Melenovský, B. Merkely, J. Núñez, E. Perna, M. Schou, M. Senni, K. Sharma, P.v.d. Meer, D.V. Lewinski, D. Wolf, and S.J. Shah
N Engl J Med 2024;390:1394-1407
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.